UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 366

Sortiert nach

Catechol-O-methyltransferase gene polymorphism and chronic human pain: a systematic review and meta-analysis

Pharmacogenetics and genomics, 2012-09, Vol.22 (9), p.673-691

2012

Volltextzugriff (PDF)

Site-Specific Role of Catechol-O-Methyltransferase in Dopamine Overflow within Prefrontal Cortex and Dorsal Striatum

The Journal of neuroscience, 2007-09, Vol.27 (38), p.10196-10209

2007

Volltextzugriff (PDF)

Epistasis between polymorphisms in COMT, ESR1, and GCH1 influences COMT enzyme activity and pain

Pain (Amsterdam), 2014-11, Vol.155 (11), p.2390-2399

2014

Volltextzugriff (PDF)

Mechanism of Action of Prolyl Oligopeptidase (PREP) in Degenerative Brain Diseases: Has Peptidase Activity Only a Modulatory Role on the Interactions of PREP with Proteins?

Frontiers in aging neuroscience, 2017-02, Vol.9, p.27-27

2017

Volltextzugriff (PDF)

Distribution of catechol-O-methyltransferase (COMT) proteins and enzymatic activities in wild-type and soluble COMT deficient mice

Journal of neurochemistry, 2010-06, Vol.113 (6), p.1632-1643

2010

Volltextzugriff (PDF)

Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cγ signaling pathways in mouse brain

Neuropsychopharmacology (New York, N.Y.), 2007-10, Vol.32 (10), p.2152-2162

2007

Volltextzugriff (PDF)

Are genetic variants of COMT associated with addiction?

Pharmacogenetics and genomics, 2010-12, Vol.20 (12), p.717-741

2010

Volltextzugriff (PDF)

Delayed O-methylation of l-DOPA in MB-COMT-deficient mice after oral administration of l-DOPA and carbidopa

Xenobiotica, 2018-04, Vol.48 (4), p.325-331

2018

Volltextzugriff (PDF)

Catechol-O-methyltransferase (COMT) protein expression and activity after dopaminergic and noradrenergic lesions of the rat brain

PloS one, 2013-04, Vol.8 (4), p.e61392

2013

Volltextzugriff (PDF)

The multiple faces of quercetin in neuroprotection

Expert opinion on drug safety, 2009-07, Vol.8 (4), p.397-409

2009

Volltextzugriff (PDF)

Issues About the Physiological Functions of Prolyl Oligopeptidase Based on Its Discordant Spatial Association With Substrates and Inconsistencies Among mRNA, Protein Levels, and Enzymatic Activity

The journal of histochemistry and cytochemistry, 2009-09, Vol.57 (9), p.831-848

2009

Volltextzugriff (PDF)

Distribution of Prolyl Oligopeptidase in Human Peripheral Tissues and in Ovarian and Colorectal Tumors

The journal of histochemistry and cytochemistry, 2012-09, Vol.60 (9), p.706-715

2012

Volltextzugriff (PDF)

Minocycline protects SH-SY5Y cells from 6-hydroxydopamine by inhibiting both caspase-dependent and -independent programmed cell death

Journal of neuroscience research, 2012-03, Vol.90 (3), p.682-690

2012

Volltextzugriff (PDF)

Four day inhibition of prolyl oligopeptidase causes significant changes in the peptidome of rat brain, liver and kidney

Biochimie, 2012-09, Vol.94 (9), p.1849-1859

2012

Volltextzugriff (PDF)

Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons

Experimental neurology, 2009-10, Vol.219 (2), p.499-506

2009

Volltextzugriff (PDF)

Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human α-synuclein

Neurobiology of disease, 2005-11, Vol.20 (2), p.303-313

2005

Volltextzugriff (PDF)

Constitutive Ret signaling is protective for dopaminergic cell bodies but not for axonal terminals

Neurobiology of aging, 2011-08, Vol.32 (8), p.1486-1494

2011

Volltextzugriff (PDF)

Enzymatic detoxification of gluten by germinating wheat proteases: Implications for new treatment of celiac disease

Annals of medicine (Helsinki), 2009, Vol.41 (5), p.390-400

2009

Volltextzugriff (PDF)

Effect of Genetic Modifications in the Synaptic Dopamine Clearance Systems on Addiction‐like Behaviour in Mice

Basic & clinical pharmacology & toxicology, 2011-01, Vol.108 (1), p.2-8

2011

Volltextzugriff (PDF)

Effects of Diverse Psychopharmacological Substances on the Activity of Brain Prolyl Oligopeptidase

Basic & clinical pharmacology & toxicology, 2011-01, Vol.108 (1), p.46-54

2011

Volltextzugriff (PDF)

The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse

Neurobiology of disease, 2014-08, Vol.68, p.1-15

2014

Volltextzugriff (PDF)

Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice

Journal of neurochemistry, 2010-09, Vol.114 (6), p.1745-1755

2010

Volltextzugriff (PDF)

A Transient Inhibition and Permanent Lack of Catechol-O-Methyltransferase have Minor Effects on Feeding Pattern of Female Rodents

Basic & clinical pharmacology & toxicology, 2012-04, Vol.110 (4), p.307-313

2012

Volltextzugriff (PDF)

Sequential Expression, Activity and Nuclear Localization of Prolyl Oligopeptidase Protein in the Developing Rat Brain

Developmental neuroscience, 2011-01, Vol.33 (1), p.38-47

2011

Volltextzugriff (PDF)

Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors

Biochemical pharmacology, 2006-02, Vol.71 (5), p.683-692

2006

Volltextzugriff (PDF)

1 – 25 von 366

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(324)
Mit Volltextzugriff
(326)

Publikationsform

Sprache

Englisch
(366)
Japanisch
(44)
Russisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(266)
Life Sciences & Biomedicine
(250)
Animals
(180)
Male
(170)
Biological And Medical Sciences
(125)
Rats
(108)
Medical Sciences
(100)
Pharmacology & Pharmacy
(100)
Humans
(96)
Female
(75)
Pharmacology. Drug Treatments
(71)
Rats, Wistar
(68)
Neurosciences
(53)
Neurosciences & Neurology
(52)
Adult
(43)
Middle Aged
(41)
Mice
(40)
Fundamental And Applied Biological Sciences. Psychology
(36)
Neuropharmacology
(34)
Toxicology
(33)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Catechol-O-methyltransferase gene polymorphism and chronic human pain: a systematic review and meta-analysis

Site-Specific Role of Catechol-O-Methyltransferase in Dopamine Overflow within Prefrontal Cortex and Dorsal Striatum

Epistasis between polymorphisms in COMT, ESR1, and GCH1 influences COMT enzyme activity and pain

Mechanism of Action of Prolyl Oligopeptidase (PREP) in Degenerative Brain Diseases: Has Peptidase Activity Only a Modulatory Role on the Interactions of PREP with Proteins?

Distribution of catechol-O-methyltransferase (COMT) proteins and enzymatic activities in wild-type and soluble COMT deficient mice

Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cγ signaling pathways in mouse brain

Are genetic variants of COMT associated with addiction?

Delayed O-methylation of l-DOPA in MB-COMT-deficient mice after oral administration of l-DOPA and carbidopa

Catechol-O-methyltransferase (COMT) protein expression and activity after dopaminergic and noradrenergic lesions of the rat brain

The multiple faces of quercetin in neuroprotection

Issues About the Physiological Functions of Prolyl Oligopeptidase Based on Its Discordant Spatial Association With Substrates and Inconsistencies Among mRNA, Protein Levels, and Enzymatic Activity

Distribution of Prolyl Oligopeptidase in Human Peripheral Tissues and in Ovarian and Colorectal Tumors

Minocycline protects SH-SY5Y cells from 6-hydroxydopamine by inhibiting both caspase-dependent and -independent programmed cell death

Four day inhibition of prolyl oligopeptidase causes significant changes in the peptidome of rat brain, liver and kidney

Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons

Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human α-synuclein

Constitutive Ret signaling is protective for dopaminergic cell bodies but not for axonal terminals

Enzymatic detoxification of gluten by germinating wheat proteases: Implications for new treatment of celiac disease

Effect of Genetic Modifications in the Synaptic Dopamine Clearance Systems on Addiction‐like Behaviour in Mice

Effects of Diverse Psychopharmacological Substances on the Activity of Brain Prolyl Oligopeptidase

The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse

Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice

A Transient Inhibition and Permanent Lack of Catechol-O-Methyltransferase have Minor Effects on Feeding Pattern of Female Rodents

Sequential Expression, Activity and Nuclear Localization of Prolyl Oligopeptidase Protein in the Developing Rat Brain

Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors

Suchergebnisse filtern